Free Trial
NASDAQ:TFFP

TFF Pharmaceuticals (TFFP) Stock Price, News & Analysis

TFF Pharmaceuticals logo
$0.06 0.00 (0.00%)
As of 04/10/2025

About TFF Pharmaceuticals Stock (NASDAQ:TFFP)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.07
52-Week Range
$0.06
$3.23
Volume
N/A
Average Volume
983,915 shs
Market Capitalization
$288.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TFFP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TFFP Stock News Headlines

TFF Pharmaceuticals approves dissolution plan
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
TFF Pharmaceuticals Shares Fall 66%; Company to Wind Down
TFF Pharmaceuticals terminates employees, to wind down operations
TFF Pharmaceuticals to Dissolve and Liquidate Assets
TFF Pharmaceuticals Announces It Will Wind Down Operations
See More Headlines

TFFP Stock Analysis - Frequently Asked Questions

TFF Pharmaceuticals' stock was trading at $0.0650 at the beginning of the year. Since then, TFFP stock has increased by 0.0% and is now trading at $0.0650.

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) released its earnings results on Wednesday, November, 20th. The company reported ($0.81) earnings per share (EPS) for the quarter.

TFF Pharmaceuticals's stock reverse split before market open on Tuesday, December 19th 2023.The 1-25 reverse split was announced on Tuesday, December 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

TFF Pharmaceuticals (TFFP) raised $22 million in an initial public offering on Friday, October 25th 2019. The company issued 4,400,000 shares at $5.00 per share. National Securities served as the underwriter for the IPO.

Shares of TFFP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TFF Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CymaBay Therapeutics (CBAY), GE Aerospace (GE), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
11/20/2024
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TFFP
CIK
1733413
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$730 thousand
Price / Sales
0.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.02

Miscellaneous

Outstanding Shares
4,440,000
Free Float
4,244,000
Market Cap
$288.60 thousand
Optionable
Optionable
Beta
0.98
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:TFFP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners